Being a better social media citizen at the 2017 ASCO Annual Meeting

You’ll experience AstraZeneca’s social media activity differently this year during the 2017 ASCO Annual Meeting. We listened to concerns raised by attendees and others engaging online that valuable conversations on social media may be overshadowed by content from companies with large followings and more resources. We feel a responsibility to preserve this vital space online where the oncology community convenes to learn, discuss and share the science that excites them at ASCO 2017 from onsite and around the world.

We’ve listened and this year we’re committing to changing our approach to social media during the 2017 ASCO Annual Meeting. This means we’ll not only proactively talk, but also listen and share more of the great conversations that we see online. Here are our social media commitments for our activity during ASCO 2017, to be better social media citizens, to elevate valuable conversations and, when appropriate, to contribute our own unique perspective. We look forward to connecting with you at #ASCO17!

Our commitments



Talk less and listen more. We’re significantly reducing our volume of original tweets compared to previous years.


Elevate important voices. We follow the researchers, patient organizations, doctors and patients during the 2017 ASCO Annual Meeting and we’ll be doing a lot of retweeting, commenting, and marking our favorite tweets from diverse voices at the conference.


Be sensitive – cancer is serious. We take cancer very seriously and we understand how it impacts lives. Our content will seek to contribute to the serious scientific and personal discussions taking place at the 2017 ASCO Annual Meeting –  no #DYKs, quizzes or anything to trivialize the disease.


Respect the organic conversation. We will not promote any tweets with paid advertising during the 2017 ASCO Annual Meeting in support of letting the most compelling content naturally rise to the top.


Make complex science accessible. We can bring the greatest value to the conversation by focusing on what we do best – explaining our science first and foremost. We’ll use compelling, easy-to-digest formats to make our science clear and easy to understand.